Vascular Endothelial Growth Factor (VEGF)-A165b Is a Weak In vitro Agonist for VEGF Receptor-2 Due to Lack of Coreceptor Binding and Deficient Regulation of Kinase Activity

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,114 · see citing works

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931 · see citing works

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,624 · see citing works

VEGF receptor signalling ? in control of vascular function

Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122 · see citing works

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Soker, S., Takashima, S., Miao, H., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,634 · see citing works

Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

Waltenberger, J. L., Claesson, L., Siegbahn, A., Shibuya, M., & Heldin, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656 · see citing works

Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate

Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495 · see citing works

Neuropilin is a semaphorin III receptor.

Kolodkin, A., Levengood, D. V., Rowe, E. G., Tai, Y.-T., Giger, R., & Ginty, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80535-8 · Cited by 1,262 · see citing works

Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III

He, Z., & Tessier‐Lavigne, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80534-6 · Cited by 1,137 · see citing works

VEGF-receptor signal transduction

Cross, M. J., Dixelius, J., Matsumoto, T., & Claesson, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00193-2 · Cited by 864 · see citing works

A requirement for neuropilin-1 in embryonic vessel formation

Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T., & Fujisawa, H. (1999) · Development · doi:10.1242/dev.126.21.4895 · Cited by 828 · see citing works

Untitled work

(2002) · PubMed · Cited by 550 · see citing works

VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix

Gluzman‐Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodavsky, I., Keshet, E., & Neufeld, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7151 · Cited by 519 · see citing works

Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site

Muller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., & de Vos, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7192 · Cited by 452 · see citing works

VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant

Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451 · see citing works

The Mouse Gene for Vascular Endothelial Growth Factor

Shima, D. T., Kuroki, M., Deutsch, U., Ng, Y., Adamis, A. P., & D'Amore, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3877 · Cited by 326 · see citing works

The role of VEGF in the regulation of physiological and pathological angiogenesis

Ferrara, N. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7311-3_15 · Cited by 313 · see citing works

VEGF receptor‐2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis

Matsumoto, T., Bohman, S., Dixelius, J., Berge, T., Dimberg, A., Magnusson, P. U., Ling, W., Wikner, C., Qi, J. H., Wernstedt, C., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600709 · Cited by 292 · see citing works

Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation Sites

Dixelius, J., Mäkinen, T., Wirzenius, M., Karkkainen, M. J., Wernstedt, C., Alitalo, K. K., & Claesson, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304499200 · Cited by 285 · see citing works

Heparan Sulfate in trans Potentiates VEGFR-Mediated Angiogenesis

Jakobsson, L., Kreuger, J., Holmborn, K., Lundin, L., Eriksson, I., Kjellén, L., & Claesson, L. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.009 · Cited by 275 · see citing works

VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

Varey, A. H. R., Rennel, E. S., Qiu, Y., Bevan, H. S., Perrin, R. M., Raffy, S., Dixon, A., Paraskeva, C., Zaccheo, O., Hassan, A. B., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604308 · Cited by 224 · see citing works

A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2

Suarez, S., Pieren, M., Cariolato, L., Arn, S., Hoffmann, U., Bogucki, A., Manlius, C., Wood, J. M., & Ballmer‐Hofer, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6254-9 · Cited by 198 · see citing works

Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt 1

Landgren, E., Schiller, P., Cao, Y., & Claesson, L. (1998) · Oncogene · doi:10.1038/sj.onc.1201545 · Cited by 167 · see citing works

Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling

Jia, H., Bagherzadeh, A., Hartzoulakis, B., Jarvis, A., Löhr, M., Shaikh, S., Aqil, R., Cheng, L., Tickner, M. L., Esposito, D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512121200 · Cited by 138 · see citing works

The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice

Rennel, E. S., Waine, E., Guan, H., Schüler, Y., Leenders, W. P. J., Woolard, J., Sugiono, M., Gillatt, D. A., Kleinerman, E. S., Bates, D. O., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604309 · Cited by 124 · see citing works

Identification of Vascular Endothelial Growth Factor Receptor-1 Tyrosine Phosphorylation Sites and Binding of SH2 Domain-containing Molecules

Ito, N., Wernstedt, C., Engström, U., & Claesson, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23410 · Cited by 113 · see citing works

Identification of a Heparin Binding Peptide on the Extracellular Domain of the KDR VEGF Receptor

Dougher, A. M., Wasserstrom, H. A., Torley, L. W., Shridaran, L., Westdock, P., Hileman, R. E., Fromm, J. R., Anderberg, R. J., Lyman, S. D., Linhardt, R. J., et al. (1997) · Growth Factors · doi:10.3109/08977199709021524 · Cited by 95 · see citing works

Building blood vessels—stem cell models in vascular biology

Jakobsson, L., Kreuger, J., & Claesson‐Welsh, L. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701146 · Cited by 93 · see citing works

Recombinant human VEGF165b protein is an effective anti-cancer agent in mice

Rennel, E., Hamdollah‐Zadeh, M., Wheatley, E. R., Magnussen, A., Schüler, Y., Kelly, S., Finucane, C. M., Ellison, D. H., Suarez, S., Ballmer‐Hofer, K., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.05.027 · Cited by 80 · see citing works

Nitrocellulose Filter Binding to Assess Binding of Glycosaminoglycans to Proteins

Kreuger, J., Lindahl, U., & Jemth, P. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)01062-0 · Cited by 27 · see citing works

Lentiviral Rescue of Vascular Endothelial Growth Factor Receptor-2 Expression in Flk1−/− Embryonic Stem Cells Shows Early Priming of Endothelial Precursors

Li, X., Edholm, D., Lanner, F., Breier, G., Farnebo, F. A., Dimberg, A., & Claesson, L. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0397 · Cited by 16 · see citing works

Signal Transduction by Vascular Endothelial Growth Factor Receptors

Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson, L. (2011) · Biochemical Journal · doi:10.1042/bj20110301 · Cited by 1,629 · see citing works

Mechanisms and regulation of endothelial VEGF receptor signalling

Simons, M., Gordon, E., & Claesson-Welsh, L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.87 · Cited by 1,498 · see citing works

Molecular control of endothelial cell behaviour during blood vessel morphogenesis

Herbert, S. P., & Stainier, D. Y. R. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3176 · Cited by 1,049 · see citing works

Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedPreprint

David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 815 · see citing works

Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis

Sawamiphak, S., Seidel, S., Essmann, C. L., Wilkinson, G. A., Pitulescu, M. E., Acker, T., & Acker‐Palmer, A. (2010) · Nature · doi:10.1038/nature08995 · Cited by 532 · see citing works

Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2

Peach, C. J., Mignone, V. W., Arruda, M. A., Alcobia, D. C., Hill, S. J., Kilpatrick, L. E., & Woolard, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041264 · Cited by 517 · see citing works

VEGF-A splicing: the key to anti-angiogenic therapeutics?

Harper, S. J., & Bates, D. O. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2505 · Cited by 515 · see citing works

Biology and therapeutic targeting of vascular endothelial growth factor A

Pérez, L., & Ferrara, N. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00631-w · Cited by 515 · see citing works

Extracellular regulation of VEGF: Isoforms, proteolysis, and vascular patterning

Vempati, P., Popel, A. S., & Gabhann, F. M. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.11.002 · Cited by 313 · see citing works

Misregulation of Pre-mRNA Alternative Splicing in Cancer

Zhang, J., & Manley, J. L. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0253 · Cited by 306 · see citing works

WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing

Amin, E. M., Oltean, S., Hua, J., Gammons, M. V. R., Hamdollah‐Zadeh, M., Welsh, G. I., Cheung, M., Ni, L., Kase, S., Rennel, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.016 · Cited by 254 · see citing works

Structure and function of VEGF receptors

Stuttfeld, E., & Ballmer‐Hofer, K. (2009) · IUBMB Life · doi:10.1002/iub.234 · Cited by 234 · see citing works

VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level

Arcondéguy, T., Lacazette, É., Millevoi, S., Prats, H., & Touriol, C. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt539 · Cited by 237 · see citing works

Intrinsically disordered proteins play diverse roles in cell signaling

Bondos, S. E., Dunker, A. K., & Uversky, V. N. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00821-7 · Cited by 222 · see citing works

Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer

Tugues, S., Koch, S., Gualandi, L., Li, X., & Claesson, L. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.004 · Cited by 206 · see citing works

Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output

Ballmer‐Hofer, K., Andersson, A., Ratcliffe, L. E. K., & Berger, P. (2011) · Blood · doi:10.1182/blood-2011-01-328773 · Cited by 202 · see citing works

An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease

Kikuchi, R., Nakamura, K., MacLauchlan, S., Ngo, D. T. M., Shimizu, I., Fuster, J. J., Katanasaka, Y., Yoshida, S., Qiu, Y., Yamaguchi, T. P., et al. (2014) · Nature Medicine · doi:10.1038/nm.3703 · Cited by 196 · see citing works

The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy

Mabeta, P., & Steenkamp, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415585 · Cited by 188 · see citing works

VEGF receptor 2/‐3 heterodimers detected in situ by proximity ligation on angiogenic sprouts

Nilsson, I., Bahram, F., Li, X., Gualandi, L., Koch, S., Jarvius, M., Söderberg, O., Anisimov, A., Kholová, I., Pytowski, B., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.30 · Cited by 185 · see citing works

Mechanisms of resistance to antiangiogenesis therapy

Azam, F., Mehta, S., & Harris, A. L. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.020 · Cited by 179 · see citing works

Targeting VEGF in eye neovascularization: What's new?

Amadio, M., Govoni, S. M., & Pascale, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.027 · Cited by 176 · see citing works

Structure–function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling

Grünewald, F. S., Prota, A. E., Giese, A., & Ballmer‐Hofer, K. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.002 · Cited by 158 · see citing works

Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity

Woolard, J., Bevan, H. S., Harper, S. J., & Bates, D. O. (2009) · Microcirculation · doi:10.1080/10739680902997333 · Cited by 151 · see citing works

Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy

Oltean, S., Qiu, Y., Ferguson, J., Stevens, M., Neal, C., Russell, A., Kaura, A., Arkill, K. P., Harris, K., Symonds, C., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040350 · Cited by 136 · see citing works

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis

Girolamo, F., Coppola, C., Ribatti, D., & Trojano, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0084-z · Cited by 124 · see citing works

Antiangiogenic VEGF 165 b Regulates Macrophage Polarization via S100A8/S100A9 in Peripheral Artery Disease

Ganta, V. C., Choi, M., Farber, C. R., & Annex, B. H. (2019) · Circulation · doi:10.1161/circulationaha.118.034165 · Cited by 123 · see citing works

Vascular Growth Factors and Glomerular Disease

Bartlett, C. S., Jeansson, M., & Quaggin, S. E. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105412 · Cited by 114 · see citing works

VEGF-A165b Is an Endogenous Neuroprotective Splice Isoform of Vascular Endothelial Growth Factor A in Vivo and in Vitro

Beazley‐Long, N., Hua, J., Jehle, T., Hulse, R. P., Dersch, R. S., Lehrling, C., Bevan, H. S., Qiu, Y., Lagrèze, W. A., Wynick, D., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.031 · Cited by 116 · see citing works

Alternative Splicing in Angiogenesis

Bowler, E., & Oltean, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092067 · Cited by 108 · see citing works

The anti-angiogenic isoforms of VEGF in health and disease

Qiu, Y., Hoareau‐Aveilla, C., Oltean, S., Harper, S. J., & Bates, D. O. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371207 · Cited by 102 · see citing works

Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia

Hulse, R. P., Beazley‐Long, N., Hua, J., Kennedy, H. J., Prager, J., Bevan, H. S., Qiu, Y., Fernandes, E. S., Gammons, M. V. R., Ballmer‐Hofer, K., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.012 · Cited by 89 · see citing works

VEGF 165 b Modulates Endothelial VEGFR1–STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease

Ganta, V. C., Choi, M., Kutateladze, A. A., & Annex, B. H. (2016) · Circulation Research · doi:10.1161/circresaha.116.309516 · Cited by 90 · see citing works

VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer

Biselli-Chicote, P. M., Oliveira, A. R. C. P., Pavarino, É. C., & Goloni‐Bertollo, E. M. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1073-2 · Cited by 88 · see citing works

VEGF-A 165 b Is Cytoprotective and Antiangiogenic in the Retina

Magnussen, A., Rennel, E., Hua, J., Bevan, H. S., Beazley‐Long, N., Lehrling, C., Gammons, M. V. R., Floege, J., Harper, S. J., Agostini, H. T., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4296 · Cited by 86 · see citing works

The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo

Merdzhanova, G., Gout, S., Kéramidas, M., Edmond, V., Coll, J., Brambilla, C., Brambilla, E. M., Gazzéri, S., & Eymin, B. (2010) · Oncogene · doi:10.1038/onc.2010.281 · Cited by 84 · see citing works

The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling

Mattila, E., Auvinen, K., Salmi, M., & Ivaska, J. (2008) · Journal of Cell Science · doi:10.1242/jcs.031898 · Cited by 80 · see citing works

Evidence for Pro-angiogenic Functions of VEGF-Ax

Xin, H., Zhong, C., Nudleman, E., & Ferrara, N. (2016) · Cell · doi:10.1016/j.cell.2016.08.054 · Cited by 77 · see citing works

VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A

Catena, R., Larzábal, L., Larráyoz, M., Molina, E., Hermida, J., Agorreta, J., Montes, R., Pı́o, R., Montuenga, L. M., & Calvo, A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-320 · Cited by 72 · see citing works

How VEGF-A and its splice variants affect breast cancer development – clinical implications

Kawas, H. A., Saaid, I., Jank, P., Westhoff, C. C., Denkert, C., Pross, T., Weiler, K. B. S., & Karsten, M. M. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00665-w · Cited by 72 · see citing works

Wnt5a and its signaling pathway in angiogenesis

Shi, Y., Zhu, N., Liu, C., Wu, H., Gui, Y., Liao, D., & Li, Q. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.06.017 · Cited by 72 · see citing works

Therapeutic angiogenesis-based strategy for peripheral artery disease

Han, J., Luo, L., Marcelina, O., Kasim, V., & Wu, S. (2022) · Theranostics · doi:10.7150/thno.74785 · Cited by 72 · see citing works

Splicing in oncogenesis and tumor suppression

Kaida, D., Schneider‐Poetsch, T., & Yoshida, M. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02356.x · Cited by 67 · see citing works

VEGF Receptor Tyrosine Kinases

Álvarez-Aznar, A., Muhl, L., & Gaengel, K. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.10.001 · Cited by 64 · see citing works

Antiangiogenic Therapy for Diabetic Nephropathy

Tanabe, K., Maeshima, Y., Sato, Y., & Wada, J. (2017) · BioMed Research International · doi:10.1155/2017/5724069 · Cited by 65 · see citing works

The balance of proangiogenic and antiangiogenic VEGFA isoforms regulate follicle development

McFee, R. M., Rozell, T. G., & Cupp, A. S. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1330-y · Cited by 64 · see citing works

New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation

Delcombel, R., Janssen, L., Vassy, R., Gammons, M. V. R., Haddad, O., Richard, B., Letourneur, D., Bates, D. O., Hendricks, C., Waltenberger, J. L., et al. (2012) · Angiogenesis · doi:10.1007/s10456-012-9320-y · Cited by 64 · see citing works

VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking and proteolysis

Fearnley, G. W., Smith, G. A., Abdul‐Zani, I., Yuldasheva, N. Y., Mughal, N. A., Homer‐Vanniasinkam, S., Kearney, M. T., Zachary, I. C., Tomlinson, D. C., Harrison, M. A., et al. (2016) · Biology Open · doi:10.1242/bio.017434 · Cited by 62 · see citing works

Abnormal Histone Methylation Is Responsible for Increased Vascular Endothelial Growth Factor 165a Secretion from Airway Smooth Muscle Cells in Asthma

Clifford, R. L., John, A. E., Brightling, C. E., & Knox, A. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103641 · Cited by 61 · see citing works

Impaired Angiogenesis in Systemic Sclerosis: The Emerging Role of the Antiangiogenic VEGF165b Splice Variant

Manetti, M., Guiducci, S., Ibba‐Manneschi, L., & Matucci‐Cerinic, M. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.05.011 · Cited by 59 · see citing works

Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src

Sjöberg, E., Melssen, M. M., Richards, M., Ding, Y., Chanoca, C., Chen, D., Nwadozi, E., Pal, S., Love, D. T., Ninchoji, T., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci161366 · Cited by 58 · see citing works

Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis

Stevens, M., & Oltean, S. (2019) · Cells · doi:10.3390/cells8040288 · Cited by 56 · see citing works

VEGF-A splice variants bind VEGFRs with differential affinities

Mamer, S. B., Wittenkeller, A., & Imoukhuede, P. I. (2020) · Scientific Reports · doi:10.1038/s41598-020-71484-y · Cited by 55 · see citing works

Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model

Clegg, L. E., & Gabhann, F. M. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004158 · Cited by 55 · see citing works

The role of VEGF165b in pathophysiology

Peiris‐Pagès, M. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.22439 · Cited by 55 · see citing works

VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop

Boudria, A., Abou Faycal, C., Jia, T., Gout, S., Keramidas, M., Didier, C., Lemaître, N., Manet, S., Coll, J.-L., Toffart, A.-C., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0486-7 · Cited by 53 · see citing works

Real-time analysis of the binding of fluorescent VEGF 165 a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexes

Kilpatrick, L. E., Ohana, R. F., Alcobia, D. C., Riching, K. M., Peach, C. J., Wheal, A. J., Briddon, S. J., Robers, M. B., Zimmerman, K., Machleidt, T., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.006 · Cited by 53 · see citing works

The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor

Friedli, A., Fischer, E., Novak‐Hofer, I., Cohrs, S., Ballmer‐Hofer, K., Schubiger, P. A., Schibli, R., & Grünberg, J. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.01.006 · Cited by 52 · see citing works

Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis

Romano, E., Chora, I., Manetti, M., Mazzotta, C., Rosa, I., Bellando-Randone, S., Blagojević, J., Soares, R. A., Avouac, J., Allanore, Y., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207483 · Cited by 51 · see citing works

Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale

Harris, S., Craze, M. L., Newton, J., Fisher, M. L., Shima, D. T., Tozer, G. M., & Kanthou, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035231 · Cited by 51 · see citing works

Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy

Fayçal, C. A., Hatat, A., Gazzéri, S., & Eymin, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020383 · Cited by 51 · see citing works

Mechanisms regulating angiogenesis underlie seasonal control of pituitary function

Castle-Miller, J., Bates, D. O., & Tortonese, D. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618917114 · Cited by 50 · see citing works

VEGFA165 gene therapy ameliorates blood-labyrinth barrier breakdown and hearing loss

Zhang, J., Hou, Z., Wang, X., Jiang, H., Neng, L., Zhang, Y., Yu, Q. T., Burwood, G., Song, J., Auer, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143285 · Cited by 52 · see citing works

VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo

Rennel, E. S., Varey, A. H. R., Churchill, A. J., Wheatley, E. R., Stewart, L., Mather, S. J., Bates, D. O., & Harper, S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605249 · Cited by 48 · see citing works

BDNF (Brain-Derived Neurotrophic Factor) Promotes Embryonic Stem Cells Differentiation to Endothelial Cells Via a Molecular Pathway, Including MicroRNA-214, EZH2 (Enhancer of Zeste Homolog 2), and eNOS (Endothelial Nitric Oxide Synthase)

Descamps, B., Saif, J., Benest, A. V., Biglino, G., Bates, D. O., Chamorro-Jorganes, A., & Emanueli, C. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311400 · Cited by 47 · see citing works

An unexpected tail of VEGF and PlGF in pre-eclampsia

Bates, D. O. (2011) · Biochemical Society Transactions · doi:10.1042/bst20110671 · Cited by 44 · see citing works

VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing

Guyot, M., & Pagès, G. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2917-7_1 · Cited by 43 · see citing works

The role of neuropilins in cell signalling

Zachary, I. C., Frankel, P., Evans, I. M., & Pellet‐Many, C. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371171 · Cited by 43 · see citing works

Overexpression of VEGF165b in Podocytes Reduces Glomerular Permeability

Qiu, Y., Ferguson, J., Oltean, S., Neal, C., Kaura, A., Bevan, H. S., Wood, E., Sage, L. M., Lanati, S., Nowak, D. G., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060617 · Cited by 42 · see citing works

VEGF in the lung: a role for novel isoforms

Varet, J., Douglas, S. K., Gilmartin, L., Medford, A. R. L., Bates, D. O., Harper, S. J., & Millar, A. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00353.2009 · Cited by 41 · see citing works

Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease

Stevens, M., & Oltean, S. (2018) · Genes · doi:10.3390/genes9020098 · Cited by 41 · see citing works

Coordination of VEGF receptor trafficking and signaling by coreceptors

Nakayama, M., & Berger, P. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.008 · Cited by 40 · see citing works

Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells

Peach, C. J., Kilpatrick, L. E., Ohana, R. F., Zimmerman, K., Robers, M. B., Wood, K. V., Woolard, J., & Hill, S. J. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.06.012 · Cited by 39 · see citing works

VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells

Ourradi, K., Blythe, T., Jarrett, C., Barratt, S. L., Welsh, G. I., & Millar, A. (2017) · Respiratory Research · doi:10.1186/s12931-017-0602-1 · Cited by 38 · see citing works

VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis

Beazley‐Long, N., Hodge, D., Ashby, W. R., Bestall, S. M., Almahasneh, F. A., Durrant, A. M., Benest, A. V., Blackley, Z., Ballmer‐Hofer, K., Hirashima, M., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.012 · Cited by 38 · see citing works

Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis

Kim, Y., Bae, J., Shin, T.-H., Kang, S. H., Jeong, M., Han, Y., Park, J., Kim, S.-K., & Kim, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.016 · Cited by 35 · see citing works

Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A165a, VEGF-A165b, PIGF and VE-cadherin

Pang, V., Bates, D. O., & Leach, L. (2017) · Clinical Science · doi:10.1042/cs20171252 · Cited by 34 · see citing works

VEGF-A121a binding to Neuropilins – A concept revisited

Sarabipour, S., & Gabhann, F. M. (2017) · Cell Adhesion & Migration · doi:10.1080/19336918.2017.1372878 · Cited by 34 · see citing works

Conformational remodeling of the fibronectin matrix selectively regulates VEGF signaling

Ambesi, A., & McKeown‐Longo, P. J. (2014) · Journal of Cell Science · doi:10.1242/jcs.150458 · Cited by 32 · see citing works

Vascular endothelial growth factor A: just one of multiple mechanisms for sex-specific vascular development within the testis?

Sargent, K. M., McFee, R. M., Gomes, R. S., & Cupp, A. S. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0342 · Cited by 32 · see citing works

Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators

Bates, D. O., Beazley‐Long, N., Benest, A. V., Ye, X., Ved, N., Hulse, R. P., Barratt, S. L., Machado, M. J. C., Donaldson, L. F., Harper, S. J., et al. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170015 · Cited by 35 · see citing works

Dynamics and implications of circulating anti-angiogenic VEGF-A165b isoform in patients with ST-elevation myocardial infarction

Hueso, L., Ríos‐Navarro, C., Ruiz‐Saurí, A., Chorro, F. J., Núñez, J. E., Sanz, M., Bodı́, V., & Piqueras, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-10505-9 · Cited by 31 · see citing works

VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment

Karsten, M. M., Beck, M. H., Rademacher, A., Knabl, J., Blohmer, J., Jückstöck, J., Radosa, J. C., Jank, P., Rack, B. K., & Janni, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-59823-5 · Cited by 31 · see citing works

Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review

Supe, S., Upadhya, A., & Singh, K. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108329 · Cited by 31 · see citing works

Therapeutic Potential of Manipulating VEGF Splice Isoforms in Oncology

Rennel, E., Harper, S. J., & Bates, D. O. (2009) · Future Oncology · doi:10.2217/fon.09.33 · Cited by 30 · see citing works

VEGFA splicing: divergent isoforms regulate spermatogonial stem cell maintenance

Sargent, K. M., Clopton, D. T., Lu, N., Pohlmeier, W. E., & Cupp, A. S. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2297-2 · Cited by 30 · see citing works

Altered ratios of pro‐ and anti‐angiogenic VEGF ‐A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma

Ye, X., Abou-Rayyah, Y., Bischoff, J. E., Ritchie, A., Sebire, N. J., Watts, P., Churchill, A., & Bates, D. O. (2016) · The Journal of Pathology · doi:10.1002/path.4715 · Cited by 29 · see citing works

Bevacizumab and intraocular tumors: an intriguing paradox.

el Filali, M., Ly, L. V., Luyten, G. P. M., Versluis, M., Grossniklaus, H. E., van der Velden, P. A., & Jager, M. J. (2012) · PubMed Central · Cited by 29 · see citing works

Vascular endothelial growth factor receptors and the therapeutic targeting of angiogenesis in cancer: where do we go from here?

Bruce, D. J., & Tan, P. (2011) · Cell Communication & Adhesion · doi:10.3109/15419061.2011.619673 · Cited by 27 · see citing works

VEGFR‐2‐mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes

Andrade, M. F., Carmeliet, P., Stanimirovic, D. B., & Moreno, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05660.x · Cited by 28 · see citing works

Growth of Uveal Melanoma following Intravitreal Bevacizumab

Francis, J. H., Kim, J. W., Lin, A., Folberg, R., Iyer, S., & Abramson, D. H. (2016) · Ocular Oncology and Pathology · doi:10.1159/000450859 · Cited by 27 · see citing works

Mediators involved in retinopathy of prematurity and emerging therapeutic targets

Mataftsi, A., Dimitrakos, S. A., & Adams, G. G. W. (2011) · Early Human Development · doi:10.1016/j.earlhumdev.2011.05.009 · Cited by 27 · see citing works

VEGF-A isoform-specific regulation of calcium ion flux, transcriptional activation and endothelial cell migration

Fearnley, G. W., Bruns, A. F., Wheatcroft, S. B., & Ponnambalam, S. (2015) · Biology Open · doi:10.1242/bio.201410884 · Cited by 27 · see citing works

Vascular Endothelial Growth Factor and Other Angioglioneurins

Lafuente, J. V., Ortuzar, N., Bengoetxea, H., Bulnes, S., & Argandoña, E. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00012-0 · Cited by 27 · see citing works

Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis

Chen, Y., Tai, Z., Zhu, C., Qin, Y., Zhu, Q., & Chen, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010059 · Cited by 29 · see citing works

Peripheral vascular disease: preclinical models and emerging therapeutic targeting of the vascular endothelial growth factor ligand-receptor system

Ganta, V. C., & Annex, B. H. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1940139 · Cited by 24 · see citing works

Receptor tyrosine kinase structure and function in health and disease

Karpov, O. A., Fearnley, G. W., Smith, G. A., Kankanala, J., McPherson, M. J., Tomlinson, D. C., Harrison, M. A., & Ponnambalam, S. (2015) · AIMS Biophysics · doi:10.3934/biophy.2015.4.476 · Cited by 23 · see citing works

Enhanced vascular endothelial growth factor signaling in islets contributes to β cell injury and consequential diabetes in spontaneously diabetic Torii rats

Mukai, E., Ohta, T., Kawamura, H., Lee, E.-Y., Morita, A., Sasase, T., Miyajima, K., Inagaki, N., Iwanaga, T., & Miki, T. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.023 · Cited by 24 · see citing works

Functional effects of blocking VEGF/VEGFR2 signaling in the rat urinary bladder in acute and chronic CYP-induced cystitis

Tooke, K. I., Girard, B. M., & Vizzard, M. A. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00083.2019 · Cited by 23 · see citing works

Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy

Zhuang, P., Wang, J., Tang, Z., Zhou, X.-P., Yang, Y., Quan, Z.-W., Liu, Y., & Shen, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2553 · Cited by 23 · see citing works

Claesson-Welsh L: Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity

Kawamura, H., Li, X., Harper, S. J., Al, E., Aacr, C. T., Kawamura, H., Li, X., Harper, S. J., Bates, D. O., & Claesson‐Welsh, L. (2013)

A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2

Suarez, S., Pieren, M., Cariolato, L., Arn, S., Hoffmann, U., Bogucki, A., Manlius, C., Wood, J. M., & Ballmer‐Hofer, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6254-9 · Cited by 198 · see citing works

VEGF-A splice variants bind VEGFRs with differential affinities

Mamer, S. B., Wittenkeller, A., & Imoukhuede, P. I. (2020) · Scientific Reports · doi:10.1038/s41598-020-71484-y · Cited by 55 · see citing works

Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization

Kawamura, H., Li, X., Goishi, K., van Meeteren, L. A., Jakobsson, L., Suarez, S., Shimizu, A., Edholm, D., Ballmer‐Hofer, K., Kjellén, L., et al. (2008) · Blood · doi:10.1182/blood-2007-12-125856 · Cited by 171 · see citing works

Vascular Endothelial Growth Factor Receptor-2 and Neuropilin-1 Form a Receptor Complex That Is Responsible for the Differential Signaling Potency of VEGF165 and VEGF121

Whitaker, G. B., Limberg, B. J., & Rosenbaum, J. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102315200 · Cited by 295 · see citing works